Great Initiative ESMO - Eur. Oncology 👏👏👏

Tigirlily Gold closing out #TexasLung24 with awesome 🎶 + a message of service through Musicians On Call. Service to patients should remain our “north star” 🌟 - the reason we join together at conferences. #TexasLung24 friends - please consider supporting :
musiciansoncall.org

#openaccess ESMO - Eur. Oncology ESMO Open genomic profiling in the management of #patients w rare #cancers :
Rare cancer patients show favourable response to matched therapies, with a higher ORR in early treatment lines.

#PrecisionMedicine OncoAlert 🚨

esmoopen.com/article/S2059-…

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning | Nature Medicine nature.com/articles/s4159…

In April, we celebrate National Minority Health Month. An important question to ask ourselves—how can we approach cancer #HealthEquity with careful listening, greater empathy, and cultural competency? #NMHM2024

#PLCClive24 Dr. Lynette Sholl starts the 2024 Perspectives in Lung Cancer Care from MedscapeLIVE with a great primer on biomarker testing. Reminds us that no test is perfect! Large intronic regions can make finding fusions challenging for some platforms. Advantage to using RNA!

Impressive Christine Lovly, MD, PhD at #PLCClive24 ! Especially right after a great #AACR24 where she basically was everywhere 🎤

Congratulations Laura Soucek Ignacio Melero and all researchers leading these innovative programmes

Do not exceed 2,600 characters including the abstract title, body, and table.

The Childhood Cancer Data Initiative Hub is a gateway to a wealth of data and resources in #ChildhoodCancerResearch . Explore the Hub to access data, tools, and resources that could accelerate research progress. spr.ly/6014wUDq2 #Data4ChildhoodCancer #DataSharing

Super happy to have my team supporting and attending this unique event. #TexasLung24 Stephen V Liu, MD et al.
#LCSM #TeamBayer

We want to cultivate a community of belonging within IASLC . I encourage all members to share their feedback: bit.ly/DEI-S #LCSM

It was an absolute privilege having you with us. Really inspiring 🙏🏼

💥Just published in light of AACR Annual Meeting #AACR24
🥁Our paper unveils a transformative 'Vision for democratizing Next-Generation Oncology Clinical Trials'
🙌Let's unite researchers, clinicians, patients & policymakers to make trials more inclusive & accessible. Together,

Has someone you love just been given a #lungcancer diagnosis? As a caregiver, you need support and we're here for you. LCRF.org/resources

Congratulations LUNGevity Foundation and all patients and experts involved in this discussion guide re biomarker testing for lung cancer #LCSM

Proud to work with LUNGevity Foundation & team to develop a discussion guide for biomarker testing for patients with solid tumors.

Learn more here: lungevity.org/biomarkerdiscu…

#patienteducation #lcsm

‘…the National Cancer Plan represents a whole that is greater than the sum of its parts….’ By Dr. Kimryn Rathmell #AACR24

AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, Improving Trial Design—Vivek Subbiah, MD chairs this #AACR24 plenary (Wed 4/10), featuring Maryellen Giger, Anant Madabhushi, Mia Levy, MD, PhD, & Thomas Clozel. bit.ly/3PPrND3 Anant Madabhushi Thomas Clozel

#AACR24 travel companion 🐈✈️⁩